Summary
Updated Aug 30, 2026
George M. Milne Jr. files SEC Form 4 reports at Amylyx Pharmaceuticals, Inc. (AMLX). 3 SEC Form 4 filings on record going back to 2025, most recently on 8 June 2026.
Recent Transactions
1Every recent SEC Form 4 transaction George M. Milne Jr. has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies George M. Milne Jr. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Justin B. Klee - $3.05M of AMLX open-market activity in the last 12 months
- Joshua B. Cohen - $3.04M of AMLX open-market activity in the last 12 months
- Gina Mazzariello - $866K of AMLX open-market activity in the last 12 months
- Camille L. Bedrosian - $364K of AMLX open-market activity in the last 12 months
- James M. Frates - $359K of AMLX open-market activity in the last 12 months
- Karen Firestone - $152K of AMLX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is George M. Milne Jr.?
George M. Milne Jr. is a corporate insider of Amylyx Pharmaceuticals, Inc. (AMLX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has George M. Milne Jr. submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of George M. Milne Jr.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow George M. Milne Jr. and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
